Smcr8 deficiency disrupts axonal transport-dependent lysosomal function and promotes axonal swellings and gain of toxicity in C9ALS/FTD mouse models
JournalHuman molecular genetics
PublisherOxford University Press
MetadataShow full item record
AbstractG4C2 repeat expansions in an intron of C9ORF72 cause the most common familial amyotrophic lateral sclerosis and frontotemporal dementia (collectively, C9ALS/FTD). Mechanisms and mediators of C9ALS/FTD pathogenesis remain poorly understood. C9orf72 and Smcr8 form a protein complex. Here, we show that expression of Smcr8, like C9orf72, is reduced in C9ALS/FTD mouse models and patient tissues. Since Smcr8 is highly conserved between human and mouse, we evaluated the effects of Smcr8 downregulation in mice. Smcr8 knockout (KO) mice exhibited motor behavior deficits, which resemble those of C9ALS/FTD mouse models, and displayed axonal swellings in their spinal cords and neuromuscular junctions. These deficits are caused by impaired autophagy-lysosomal functions due to disrupted axonal transport in mutant motor neurons. Consistent with its interaction with C9orf72 and their downregulation in patient tissues, Smcr8 deficiency exacerbated autophagy-lysosomal impairment in C9orf72 KO mice. The disease relevance of Smcr8 downregulation was ref lected by exacerbated axonal swellings and gain of toxicity pathology arising from Smcr8 haploinsufficiency in a mouse model of C9ALS/FTD. Thus, our in vivo studies suggested that Smcr8 deficiency impairs axonal transport dependent autophagy-lysosomal function and exacerbates axonal degeneration and gain of toxicity in C9ALS/FTD mouse models.
Amyotrophic Lateral Sclerosis
Identifier to cite or link to this itemhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85083544553&doi=10.1093%2fhmg%2fddaa012&partnerID=40&md5=cc8be5db460282d63f73c1d996743ff9; http://hdl.handle.net/10713/12667
- Smcr8 deficiency disrupts axonal transport-dependent lysosomal function and promotes axonal swellings and gain of toxicity in C9ALS/FTD mouse models.
- Authors: Liang C, Shao Q, Zhang W, Yang M, Chang Q, Chen R, Chen JF
- Issue date: 2019 Dec 1
- A Peptidylic Inhibitor for Neutralizing <sub>r</sub>(GGGGCC)<sub>exp</sub>-Associated Neurodegeneration in C9ALS-FTD.
- Authors: Zhang Q, An Y, Chen ZS, Koon AC, Lau KF, Ngo JCK, Chan HYE
- Issue date: 2019 Jun 7
- C9orf72 deficiency promotes motor deficits of a C9ALS/FTD mouse model in a dose-dependent manner.
- Authors: Shao Q, Liang C, Chang Q, Zhang W, Yang M, Chen JF
- Issue date: 2019 Mar 4
- C9orf72 and RAB7L1 regulate vesicle trafficking in amyotrophic lateral sclerosis and frontotemporal dementia.
- Authors: Aoki Y, Manzano R, Lee Y, Dafinca R, Aoki M, Douglas AGL, Varela MA, Sathyaprakash C, Scaber J, Barbagallo P, Vader P, Mäger I, Ezzat K, Turner MR, Ito N, Gasco S, Ohbayashi N, El Andaloussi S, Takeda S, Fukuda M, Talbot K, Wood MJA
- Issue date: 2017 Apr 1
- Survival and Prognostic Factors in C9orf72 Repeat Expansion Carriers: A Systematic Review and Meta-analysis.
- Authors: Glasmacher SA, Wong C, Pearson IE, Pal S
- Issue date: 2020 Mar 1